ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow growth accelerates
Q1 FY2026 investing cash flow of $97.18M (cash outflow) rose 4019.0% year over year, ahead of the +1380.2% change in trailing-twelve-month investing cash flow. Sequentially, it rose 78.7% from the prior quarter. Over 3 fiscal years it compounded at +172.0% a year.
Context
- Investing cash flow amounted to 377.4% of revenue in FY2025, up 102.9 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +4019.0% holds above the trailing-twelve-month pace of +1380.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (90M) USD
- Year-over-year change
- -691.3%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (90M) | -691.3% |
| FY2024 | 2024-12-31 | (11.37M) | -363.6% |
| FY2023 | 2023-12-31 | (2.45M) | +45.2% |
| FY2022 | 2022-12-31 | (4.47M) | -49.7% |
| FY2021 | 2021-12-31 | (2.99M) | — |
Investing Cash Flow vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1380.2% is the 2nd highest of 11, against a peer median of -9.8%.
- Investing cash flow amounts to 686.4% of revenue for ASPI, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$3.31B BRL | +3.8% | -15.9% | 5.0% | |
| LTM Mar 2026 | $300M USD | -17.1% | -90.8% | 10.3% | |
| LTM Mar 2026 | $184.82M USD | +1380.2% | +172.0% | 686.4% | |
| LTM Mar 2026 | $178.4M USD | +439.4% | — | 9.2% | |
| LTM Mar 2026 | $99.12M USD | +10888.3% | +265.8% | 253.9% | |
| LTM Mar 2026 | $85.55M USD | -28.1% | -33.9% | 3.7% | |
| LTM Mar 2026 | $70.61M USD | -2.5% | +14.0% | 5.1% | |
| LTM Mar 2026 | $32.7M USD | -54.8% | -14.5% | 2.5% | |
| LTM Apr 2026 | $28.62M USD | -62.9% | +12.6% | 5.8% | |
| LTM Mar 2026 | $19.78M USD | +115.6% | -44.0% | 14.8% | |
| LTM Mar 2026 | $1.42M USD | -97.8% | — | 0.1% | |
| Peer median (excluding ASPI) | — | -9.8% | -15.2% | 5.5% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.